Carestream Health, Inc., and National Digital Medical Archive, Inc., (NDMA), are collaborating on product integration initiatives designed to support the expansion of NDMA's national imaging network and improve customer access to its analytics and data management services.
Siemens Healthcare introduces molecular CT, a new concept in integrated imaging that provides a premium imaging platform, and is a practical solution for today's shrinking healthcare budget.
Alsace BioValley Competitivity Pole is partnering GE Healthcare in a feasibility study of the creation of a technology platform in various fields of molecular imaging to focus on research and translational medicine.
The American Association for Clinical Chemistry (AACC) and the Australasian Association of Clinical Biochemists (AACB) are joining together for the second time for a conference on major changes facing laboratorians in coming years, under the banner Laboratory Medicine - Into the Future.
“Molecular breast imaging” (MBI), a new scintigraphy method developed by US researchers, might improve early detection of breast cancer in women with dense breasts. The results of an initial clinical study were recently presented at the Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO) in Washington, DC, USA.
Atlanta-based Velocity Medical Solutions launched VelocityAI, its new molecular imaging software, at the 2008 American Association of Physicists Medicine (AAPM) in July.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
Siemens Healthcare is working on diagnostic tests for early detection and characterziation of a patient's tumor cells. The Cologne laboratories for molecular diagnostics especially concentrate on the research of breast cancer, a disease that still is number one cause of death among women. The results should help to adapt a customized therapy to the individual patient.
A team of Stanford University School of Medicine researchers has developed a new type of imaging system that can illuminate tumors in living subjects-getting pictures with a precision of nearly one-trillionth of a meter.
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
Imaging in Internal Medicine is among the main topics for 114th Congress of the German Society of Internal Medicine (March. Wiesbaden). Specialists in internal medicine, radiologists, and nuclear medicine have developed a programme that will not only provide an overview of the values of modern imaging procedures but also tackle controversial subjects.
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.
Apart from spending a year at Johns Hopkins University Hospital, Baltimore, USA, the professor has never worked anywhere other than at the Radiology Department at the University Hospital of Cattinara Hospital, Trieste, of which she is Chairman. Daniela Zimmermann asked her about what women can achieve in this field, as well as the professor's own multifarious roles and research activities.
“We have a broad set of products and services that enable healthcare providers to improve the quality and cost of patient care,” said Carestream Health's Chief Executive Officer Kevin J. Hobert with reference to Carestream´s RSNA highlights. “We have digital technology and consulting services that few companies can match, and our integrated imaging and IT solutions are helping healthcare…
The term 'molecular medicine' has quickly become synonymous with brilliantly revealing images produced by innovative imaging techniques, new biomarkers and contrast agents. At Merck Research Laboratories (MRL) a team of researchers led by Dr Andrew Plump, the firm's Executive Director and Cardiovascular Disease Franchise Integrator, are seeking biomarkers for CVDs, and co-operating with Philips…
Near-infrared fluorescence mammography works with rays of near-infrared (NIR) light instead of X-rays. Although this is thought to be a very promising technique, there have been no effective contrast agents.
In recent years molecular imaging has developed into a hot topic field in medical research, which raised high expectations.
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
The Virtual Institute for Seven Tesla Applications (VISTA) is a partnership of several Dutch universities. To evaluate the benefit of ultrahigh-field MRI the first human 7.0T whole-body research scanner, supplied by Philips Medical Systems, was installed at the Leiden University Medical Center (LUMC). Roland Plasterk, the Durch minister of education, culture and science, attended at the opening…
Besides sophisticated imaging technologies, biomarkers are the key to molecular medicine. Therefore, the development of new and more specific biomarkers is the primary aim of researchers around the world and - since this June - it is also the aim of the new founded European Institute of Molecular Imaging, a cooperation project of the University Münster, Germany and Siemens Medical Solutions.…
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.
Whilst Siemens AG in Germany is going through turbulent times, the medical branch of the business remains on steady ground.
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'